Stand Up To Cancer and the St. Baldrick’s Foundation Grant $1.86 Million to Seattle Children’s Research Institute

Stand Up To Cancer and the St. Baldrick’s Foundation, along with the American Association for Cancer Research, announced the formation of a Dream Team dedicated to childhood cancer research. Michael Jensen, MD, director of Ben Towne Center for Childhood Cancer Research at Seattle Children’s Research Institute, is one of seven members of the Dream Team.

 Stand Up To Cancer and St. Baldrick’s will provide $1.86 million in funding to Seattle Children’s Research Institute over four years for a project that unites researchers across the country in genomics and immunotherapeutics.

 Jensen’s work falls under cancer immunotherapy, in which a patient’s own T cells are genetically modified to recognize cancer cells and attack them just as unmodified cells attack a viral infection. The modified T cells make an artificial receptor that acts like a Velcro molecule, allowing them to recognize and attack cancer cells.

 Last September, Jensen and his team received the green light from the U.S. Food and Drug Administration to conduct a trial of cancer immunotherapy treatment for children and young adults with relapsed acute lymphoblastic leukemia.  

 The project is estimated to start July 1, 2013, with the first clinical trials scheduled to open within the first year.

 Read the full press release

Speak Your Mind